Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Abnormal expression of HMGB-3 is significantly associated with malignant transformation of hepatocytes.

Zheng WJ, Yao M, Fang M, Wang L, Dong ZZ, Yao DF.

World J Gastroenterol. 2018 Aug 28;24(32):3650-3662. doi: 10.3748/wjg.v24.i32.3650.

2.

Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding.

Liao P, Zeng SX, Zhou X, Chen T, Zhou F, Cao B, Jung JH, Del Sal G, Luo S, Lu H.

Mol Cell. 2017 Dec 21;68(6):1134-1146.e6. doi: 10.1016/j.molcel.2017.11.006. Epub 2017 Dec 7.

3.

Local Anesthetics Inhibit the Growth of Human Hepatocellular Carcinoma Cells.

Le Gac G, Angenard G, Clément B, Laviolle B, Coulouarn C, Beloeil H.

Anesth Analg. 2017 Nov;125(5):1600-1609. doi: 10.1213/ANE.0000000000002429.

4.

A Novel Tetraenoic Fatty Acid Isolated from Amaranthus spinosus Inhibits Proliferation and Induces Apoptosis of Human Liver Cancer Cells.

Mondal A, Guria T, Maity TK, Bishayee A.

Int J Mol Sci. 2016 Sep 22;17(10). pii: E1604. doi: 10.3390/ijms17101604.

5.

CUL4A facilitates hepatocarcinogenesis by promoting cell cycle progression and epithelial-mesenchymal transition.

Pan Y, Wang B, Yang X, Bai F, Xu Q, Li X, Gao L, Ma C, Liang X.

Sci Rep. 2015 Nov 23;5:17006. doi: 10.1038/srep17006.

6.

INHIBITORY EFFECT OF TETRAMETHYLPYRAZINE ON HEPATOCELLULAR CARCINOMA: POSSIBLE ROLE OF APOPTOSIS AND CELL CYCLE ARREST.

Cao J, Miao Q, Zhang J, Miao S, Bi L, Zhang S, Yang Q, Zhou X, Zhang M, Xie Y, Wang S.

J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2):297-306.

PMID:
26122217
7.

Kaempferol inhibits gastric cancer tumor growth: An in vitro and in vivo study.

Song H, Bao J, Wei Y, Chen Y, Mao X, Li J, Yang Z, Xue Y.

Oncol Rep. 2015 Feb;33(2):868-74. doi: 10.3892/or.2014.3662. Epub 2014 Dec 9.

PMID:
25500692
8.

Preparation of morusin from Ramulus mori and its effects on mice with transplanted H22 hepatocarcinoma.

Wan LZ, Ma B, Zhang YQ.

Biofactors. 2014 Nov-Dec;40(6):636-45. doi: 10.1002/biof.1191. Epub 2014 Nov 25.

PMID:
25422054
9.

Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice.

Li W, Hua B, Saud SM, Lin H, Hou W, Matter MS, Jia L, Colburn NH, Young MR.

Mol Carcinog. 2015 Oct;54(10):1096-109. doi: 10.1002/mc.22179. Epub 2014 May 17.

10.

In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog.

Liu H, Liang Y, Wang L, Tian L, Song R, Han T, Pan S, Liu L.

PLoS One. 2012;7(10):e48075. doi: 10.1371/journal.pone.0048075. Epub 2012 Oct 31.

11.
12.

Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma.

Huynh H, Ong R, Soo KC.

Angiogenesis. 2012 Mar;15(1):59-70. doi: 10.1007/s10456-011-9243-z. Epub 2011 Dec 21.

PMID:
22187171
13.

Altered expression of GADD45 genes during the development of chemical-mediated liver hypertrophy and liver tumor promotion in rats.

Ozawa S, Gamou T, Habano W, Inoue K, Yoshida M, Nishikawa A, Nemoto K, Degawa M.

J Toxicol Sci. 2011 Oct;36(5):613-23.

14.

Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.

Calvisi DF, Simile MM, Ladu S, Frau M, Evert M, Tomasi ML, Demartis MI, Daino L, Seddaiu MA, Brozzetti S, Feo F, Pascale RM.

Hepatology. 2011 Apr;53(4):1226-36. doi: 10.1002/hep.24174.

PMID:
21480327
15.

Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.

Frau M, Ladu S, Calvisi DF, Simile MM, Bonelli P, Daino L, Tomasi ML, Seddaiu MA, Feo F, Pascale RM.

J Hepatol. 2011 Jul;55(1):111-9. doi: 10.1016/j.jhep.2010.10.031. Epub 2010 Dec 7.

PMID:
21419759
16.

Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells.

Wang H, Ye Y, Chui JH, Zhu GY, Li YW, Fong DW, Yu ZL.

Oncol Rep. 2010 Sep;24(3):647-51.

PMID:
20664969
17.

Caffeine enhances radiosensitization to orthotopic transplant LM3 hepatocellular carcinoma in vivo.

Wang TJ, Liu ZS, Zeng ZC, Du SS, Qiang M, Zhang SM, Zhang ZY, Tang ZY, Wu WZ, Zeng HY.

Cancer Sci. 2010 Jun;101(6):1440-6. doi: 10.1111/j.1349-7006.2010.01564.x. Epub 2010 Mar 15.

18.

Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner.

Rattan R, Giri S, Hartmann LC, Shridhar V.

J Cell Mol Med. 2011 Jan;15(1):166-78. doi: 10.1111/j.1582-4934.2009.00954.x.

19.

Low-level shRNA cytotoxicity can contribute to MYC-induced hepatocellular carcinoma in adult mice.

Beer S, Bellovin DI, Lee JS, Komatsubara K, Wang LS, Koh H, Börner K, Storm TA, Davis CR, Kay MA, Felsher DW, Grimm D.

Mol Ther. 2010 Jan;18(1):161-70. doi: 10.1038/mt.2009.222. Epub 2009 Oct 20.

20.

RB has a critical role in mediating the in vivo checkpoint response, mitigating secondary DNA damage and suppressing liver tumorigenesis initiated by aflatoxin B1.

Reed CA, Mayhew CN, McClendon AK, Yang X, Witkiewicz A, Knudsen ES.

Oncogene. 2009 Dec 17;28(50):4434-43. doi: 10.1038/onc.2009.303. Epub 2009 Oct 19.

Supplemental Content

Loading ...
Support Center